The Medical Vascular Stapler market is primarily divided by surgical application, a classification that directly drives revenue allocation. Cardiovascular surgery accounts for the largest share, roughly 55 % of total sales, because staplers are essential for aortic and arterial anastomoses where rapid, hemostatic closure reduces operative time and blood loss. Thoracic surgery follows with an estimated 30 % contribution; staplers facilitate bronchial, pulmonary artery, and esophageal resections, where precision stapling mitigates postoperative air leaks. The remaining 15 % is attributed to general surgery procedures such as organ transplantation, vascular grafting, and trauma repair, where staplers are employed for larger vessel management but with lower procedural frequency. These application‑based partitions constitute the core of the Medical Vascular Stapler segmentation, enabling manufacturers to prioritize R&D and distribution channels according to the relative economic weight of each surgical domain. Forecasts indicate that growth in minimally invasive techniques will modestly expand the cardiovascular share, while emerging thoracic oncology procedures are expected to raise the thoracic proportion over the next five years.